Physician profile
Sven Hida
NPI 1750612065
$3,680.36
in general payments reported to CMS, 2019-2025
11 companies · $826 in 2025
The $826 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $504 · 2021: $207 · 2022: $112 · 2023: $1,123 · 2024: $466 · 2025: $826.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,546 · Travel and Lodging: $869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,546.37 |
| Travel and Lodging | $868.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,340.72 | 2023-2025 | Gi Genius, Dragonfly Pancreaticobiliary Scope and Instrument Channel Caps, Barrx |
| Boston Scientific Corporation | $1,117.30 | 2020-2025 | Overstitch Endoscopic Suturing System, Spyglass, Overstitch Nxt Endoscopic Suturing System |
| Covidien LP | $450.23 | 2019-2020 | |
| Ambu INC. | $371.29 | 2020-2021 | |
| Olympus America INC. | $125.22 | 2020 | |
| Apollo Endosurgery US INC | $76.94 | 2023 | Orbera Intragastric Balloon System |
| Abbvie INC. | $67.37 | 2019-2025 | |
| Enterra Medical, INC. | $61.14 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.20 | 2019 | |
| Lucid Diagnostics INC. | $24.00 | 2021 | |
| Merit Medical Systems INC | $16.95 | 2025 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sven Hida listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.